Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.22.2.2
Stockholders' Equity - Restricted Stock (Details) - Restricted Stock
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Stockholders' Equity  
Non-vested beginning balance | shares 4,512,701
Number of Shares, Granted | shares 1,594,214
Number of Shares, Forfeited | shares (84,000)
Number of Shares, Vested | shares (2,087,710)
Non-vested ending balance | shares 3,935,205
Weighted Average Exercise Price, beginning balance | $ / shares $ 3.35
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.00
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 2.75
Weighted Average Grant Date Fair Value, Vested | $ / shares 3.68
Weighted Average Exercise Price , ending balance | $ / shares $ 2.64